APA (7th ed.) Citation

NP, B., A, H., K, W., P, G., G, W., H, D., . . . S, B. (2020). A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects. Clinical drug investigation, 40(5), 433. https://doi.org/10.1007/s40261-020-00903-9

Chicago Style (17th ed.) Citation

NP, Becker, et al. "A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects." Clinical Drug Investigation 40, no. 5 (2020): 433. https://doi.org/10.1007/s40261-020-00903-9.

MLA (9th ed.) Citation

NP, Becker, et al. "A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects." Clinical Drug Investigation, vol. 40, no. 5, 2020, p. 433, https://doi.org/10.1007/s40261-020-00903-9.